These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35162472)

  • 1. Safety and Efficacy of DOACs in Patients with Advanced and End-Stage Renal Disease.
    Rogula S; Gąsecka A; Mazurek T; Navarese EP; Szarpak Ł; Filipiak KJ
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
    Alhousani M; Malik SU; Abu-Hashyeh A; Poznanski NJ; Al-Hasan S; Roth DF; Alsharedi M; Mustafa B
    Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent evidence for direct oral anticoagulants in chronic kidney disease.
    Ha JT; Badve SV; Jun M
    Curr Opin Nephrol Hypertens; 2019 May; 28(3):251-261. PubMed ID: 30789840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct oral anticoagulants in patients with chronic kidney disease: patient selection and special considerations.
    Lutz J; Jurk K; Schinzel H
    Int J Nephrol Renovasc Dis; 2017; 10():135-143. PubMed ID: 28652799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DOAC use in patients with chronic kidney disease.
    Kcükköylü S; Rump LC
    Hamostaseologie; 2017; 37(4):286-294. PubMed ID: 29582930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K Antagonists and Direct Oral Anticoagulants in Nonagenarian Patients With Atrial Fibrillation.
    Raposeiras-Roubín S; Alonso Rodríguez D; Camacho Freire SJ; Abu-Assi E; Cobas-Paz R; Rodríguez Pascual C; García Comesaña J; González-Carrero López A; Cubelos Fernández N; López-Masjuán Ríos Á; Cespón-Fernández M; Muñoz-Pousa I; Caneiro-Queija B; Rodríguez Albarrán A; Castañera SÁ; Guillén JV; Carpintero Vara A; Barreiro Pardal C; Domínguez-Erquicia P; Domínguez-Rodríguez LM; Díaz Fernández JF; Fernández Vázquez F; Iñíguez-Romo A
    J Am Med Dir Assoc; 2020 Mar; 21(3):367-373.e1. PubMed ID: 31753740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of direct oral anticoagulants in patients with chronic renal insufficiency: A review of the literature.
    Weber J; Olyaei A; Shatzel J
    Eur J Haematol; 2019 Apr; 102(4):312-318. PubMed ID: 30592337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombus: A Systematic Review and Meta-analysis.
    Burmeister C; Beran A; Mhanna M; Ghazaleh S; Tomcho JC; Maqsood A; Sajdeya O; Assaly R
    Am J Ther; 2021 Apr; 28(4):e411-e419. PubMed ID: 33852473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register.
    Palareti G; Antonucci E; Legnani C; Mastroiacovo D; Poli D; Prandoni P; Tosetto A; Pengo V; Testa S; Ageno W;
    BMJ Open; 2020 Nov; 10(11):e040449. PubMed ID: 33247017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
    Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
    Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
    Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
    J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atrial fibrillation, oral anticoagulation and nephroprotection: caution or bravery?].
    Di Lullo L; Magnocavallo M; Vetta G; Lavalle C; Barbera V; Ronco C; Paoletti E; Ravera M; Fusaro M; Russo D; De Pascalis A; Bellasi A
    G Ital Nefrol; 2022 Apr; 39(2):. PubMed ID: 35470995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Anti-vitamin k oral anticoagulants on bone and cardiovascular health.
    Marietta M; Coluccio V; Boriani G; Luppi M
    Eur J Intern Med; 2020 Sep; 79():1-11. PubMed ID: 32553585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atrial fibrillation in severe and end stage renal disease: from oral anticoagulation therapy to percutaneous left atrial appendage occlusion].
    Merella P; Casu G; Mazzone P; Lorenzoni G; D'Angelo G; Genovesi S
    G Ital Nefrol; 2019 Feb; 36(1):. PubMed ID: 30758149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Gupta S; Um KJ; Pandey A; McIntyre WF; Ivanova M; Allahverdi Y; Agahi P; Pandya F; Lopez A; Sachdeva A; Whitlock RP; Belley-Cote EP
    Cardiovasc Drugs Ther; 2019 Jun; 33(3):339-352. PubMed ID: 31011880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants.
    Ashley J; McArthur E; Bota S; Harel Z; Battistella M; Molnar AO; Jun M; Badve SV; Garg AX; Manuel D; Tanuseputro P; Wells P; Mavrakanas T; Rhodes E; Sood MM
    Am J Kidney Dis; 2020 Sep; 76(3):311-320. PubMed ID: 32333946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions with oral anticoagulants: data from sicilian spontaneous reporting system database.
    Barbieri MA; Cutroneo PM; Baratelli C; Cicala G; Battaglia A; Santoro V; Andò G; Spina E
    J Clin Pharm Ther; 2021 Aug; 46(4):1027-1040. PubMed ID: 33646603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Oral Anticoagulants Versus Vitamin K Antagonists for the Treatment of Left Ventricular Thrombi-Insights from a Swiss Multicenter Registry.
    Seiler T; Vasiliauskaite E; Grüter D; Young M; Attinger-Toller A; Madanchi M; Cioffi GM; Tersalvi G; Müller G; Stämpfli SF; de Boeck B; Suter Y; Nossen J; Toggweiler S; Wuillemin WA; Cuculi F; Kobza R; Bossard M
    Am J Cardiol; 2023 May; 194():113-121. PubMed ID: 36849314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopy-Related Bleeding and Thromboembolic Events in Patients on Direct Oral Anticoagulants or Vitamin K Antagonists.
    Rodríguez de Santiago E; Sánchez Aldehuelo R; Riu Pons F; Rodríguez Escaja C; Fernández-Esparrach G; Cañete-Ruiz Á; Ferre Aracil C; Pérez-Corte D; Ríos León R; Marcos-Prieto HM; Delgado-Guillena PG; García-Rodríguez A; Guarner-Argente C; Muriel A; de la Fuente-Briongos E; García García de Paredes A; Parejo-Carbonell S; Téllez L; Senosiaín-Lalastra C; Burgos-Santamaría D; Aicart-Ramos M; Mateos Muñoz B; Peñas-García B; Pagano G; Casals Urquiza G; Urpi Ferreruela M; Ángel de Jorge-Turrión M; Barreiro-Alonso E; Fraile-López M; Gómez-Outomuro A; Altamirano MI; Núñez Esteban M; Ruiz-Andreu M; Arribas-Anta J; de Frutos D; Herreros-de-Tejada A; Arias-Rivera ML; Roldán-Fernández M; Marcos Martín ÁF; Zamora J; Vázquez-Sequeiros E; Albillos A;
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e380-e397. PubMed ID: 33279783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease.
    Bhatia HS; Bailey J; Unlu O; Hoffman K; Kim RJ
    Pacing Clin Electrophysiol; 2019 Nov; 42(11):1463-1470. PubMed ID: 31599969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.